These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

722 related items for PubMed ID: 12719960

  • 1. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities.
    Sánchez C, Bergqvist PB, Brennum LT, Gupta S, Hogg S, Larsen A, Wiborg O.
    Psychopharmacology (Berl); 2003 Jun; 167(4):353-62. PubMed ID: 12719960
    [Abstract] [Full Text] [Related]

  • 2. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    Mansari ME, Wiborg O, Mnie-Filali O, Benturquia N, Sánchez C, Haddjeri N.
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
    [Abstract] [Full Text] [Related]

  • 3. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
    Mnie-Filali O, El Mansari M, Scarna H, Zimmer L, Sánchez C, Haddjeri N.
    Encephale; 2007 Dec; 33(6):965-72. PubMed ID: 18789789
    [Abstract] [Full Text] [Related]

  • 4. Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine.
    Owens MJ, Knight DL, Nemeroff CB.
    Biol Psychiatry; 2001 Sep 01; 50(5):345-50. PubMed ID: 11543737
    [Abstract] [Full Text] [Related]

  • 5. [Mechanisms of action of antidepressants: new data from Escitalopram].
    Fabre V, Hamon M.
    Encephale; 2003 Sep 01; 29(3 Pt 1):259-65. PubMed ID: 12876551
    [Abstract] [Full Text] [Related]

  • 6. S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
    Millan MJ, Dekeyne A, Papp M, La Rochelle CD, MacSweeny C, Peglion JL, Brocco M.
    J Pharmacol Exp Ther; 2001 Aug 01; 298(2):581-91. PubMed ID: 11454919
    [Abstract] [Full Text] [Related]

  • 7. [Second generation SSRIS: human monoamine transporter binding profile of escitalopram and R-fluoxetine].
    Owens JM, Knight DL, Nemeroff CB.
    Encephale; 2002 Aug 01; 28(4):350-5. PubMed ID: 12232544
    [Abstract] [Full Text] [Related]

  • 8. Molecular mechanism of citalopram and cocaine interactions with neurotransmitter transporters.
    Ravna AW, Sylte I, Dahl SG.
    J Pharmacol Exp Ther; 2003 Oct 01; 307(1):34-41. PubMed ID: 12944499
    [Abstract] [Full Text] [Related]

  • 9. The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors.
    Chen F, Larsen MB, Sánchez C, Wiborg O.
    Eur Neuropsychopharmacol; 2005 Mar 01; 15(2):193-8. PubMed ID: 15695064
    [Abstract] [Full Text] [Related]

  • 10. S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
    Millan MJ, Gobert A, Lejeune F, Newman-Tancredi A, Rivet JM, Auclair A, Peglion JL.
    J Pharmacol Exp Ther; 2001 Aug 01; 298(2):565-80. PubMed ID: 11454918
    [Abstract] [Full Text] [Related]

  • 11. Further studies on conformationally constrained tricyclic tropane analogues and their uptake inhibition at monoamine transporter sites: synthesis of (Z)-9-(substituted arylmethylene)-7-azatricyclo[4.3.1.0(3,7)]decanes as a novel class of serotonin transporter inhibitors.
    Zhang A, Zhou G, Hoepping A, Mukhopadhyaya J, Johnson KM, Zhang M, Kozikowski AP.
    J Med Chem; 2002 Apr 25; 45(9):1930-41. PubMed ID: 11960503
    [Abstract] [Full Text] [Related]

  • 12. R-citalopram attenuates anxiolytic effects of escitalopram in a rat ultrasonic vocalisation model.
    Sánchez C.
    Eur J Pharmacol; 2003 Mar 19; 464(2-3):155-8. PubMed ID: 12620508
    [Abstract] [Full Text] [Related]

  • 13. Blockade of the high-affinity noradrenaline transporter (NET) by the selective 5-HT reuptake inhibitor escitalopram: an in vivo microdialysis study in mice.
    Nguyen HT, Guiard BP, Bacq A, David DJ, David I, Quesseveur G, Gautron S, Sanchez C, Gardier AM.
    Br J Pharmacol; 2013 Jan 19; 168(1):103-16. PubMed ID: 22233336
    [Abstract] [Full Text] [Related]

  • 14. Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?
    Sánchez C, Meier E.
    Psychopharmacology (Berl); 1997 Feb 19; 129(3):197-205. PubMed ID: 9084057
    [Abstract] [Full Text] [Related]

  • 15. Further SAR studies of piperidine-based analogues of cocaine. 2. Potent dopamine and serotonin reuptake inhibitors.
    Tamiz AP, Zhang J, Flippen-Anderson JL, Zhang M, Johnson KM, Deschaux O, Tella S, Kozikowski AP.
    J Med Chem; 2000 Mar 23; 43(6):1215-22. PubMed ID: 10737754
    [Abstract] [Full Text] [Related]

  • 16. R-citalopram inhibits functional and 5-HTP-evoked behavioural responses to the SSRI, escitalopram.
    Sánchez C, Kreilgaard M.
    Pharmacol Biochem Behav; 2004 Feb 23; 77(2):391-8. PubMed ID: 14751469
    [Abstract] [Full Text] [Related]

  • 17. Neurokinin1 antagonists potentiate antidepressant properties of serotonin reuptake inhibitors, yet blunt their anxiogenic actions: a neurochemical, electrophysiological, and behavioral characterization.
    Gobert A, Brocco M, Dekeyne A, Di Cara B, Bouchez G, Lejeune F, Gannon RL, Millan MJ.
    Neuropsychopharmacology; 2009 Mar 23; 34(4):1039-56. PubMed ID: 18830239
    [Abstract] [Full Text] [Related]

  • 18. [11C]-NS 4194 versus [11C]-DASB for PET imaging of serotonin transporters in living porcine brain.
    Jensen SB, Smith DF, Bender D, Jakobsen S, Peters D, Nielsen EØ, Olsen GM, Scheel-Krüger J, Wilson A, Cumming P.
    Synapse; 2003 Sep 01; 49(3):170-7. PubMed ID: 12774301
    [Abstract] [Full Text] [Related]

  • 19. Chronic treatment with escitalopram but not R-citalopram translocates Galpha(s) from lipid raft domains and potentiates adenylyl cyclase: a 5-hydroxytryptamine transporter-independent action of this antidepressant compound.
    Zhang L, Rasenick MM.
    J Pharmacol Exp Ther; 2010 Mar 01; 332(3):977-84. PubMed ID: 19996298
    [Abstract] [Full Text] [Related]

  • 20. Conclusive evidence for distinct transporters for 5-hydroxytryptamine and noradrenaline in pulmonary endothelial cells of the rat.
    Paczkowski NJ, Vuocolo HE, Bryan-Lluka LJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar 01; 353(4):423-30. PubMed ID: 8935709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.